[go: up one dir, main page]

MXPA05011287A - Analogos de fosfonato anti-cancer. - Google Patents

Analogos de fosfonato anti-cancer.

Info

Publication number
MXPA05011287A
MXPA05011287A MXPA05011287A MXPA05011287A MXPA05011287A MX PA05011287 A MXPA05011287 A MX PA05011287A MX PA05011287 A MXPA05011287 A MX PA05011287A MX PA05011287 A MXPA05011287 A MX PA05011287A MX PA05011287 A MXPA05011287 A MX PA05011287A
Authority
MX
Mexico
Prior art keywords
compounds
cancer
phosphonate analogs
cancer phosphonate
analogs
Prior art date
Application number
MXPA05011287A
Other languages
English (en)
Inventor
Jennifer Zhang
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Priority claimed from PCT/US2004/013121 external-priority patent/WO2004096235A2/en
Publication of MXPA05011287A publication Critical patent/MXPA05011287A/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invencion se refiere a compuestos anti-cancer substituidos con fosforo, composiciones que contienen tales compuestos, y metodos terapeuticos que incluyen la administracion de tales compuestos, asi como a procesos e intermediarios utiles para preparar tales compuestos.
MXPA05011287A 2003-04-25 2004-04-26 Analogos de fosfonato anti-cancer. MXPA05011287A (es)

Applications Claiming Priority (126)

Application Number Priority Date Filing Date Title
US46584403P 2003-04-25 2003-04-25
US46541503P 2003-04-25 2003-04-25
US46546503P 2003-04-25 2003-04-25
US46532503P 2003-04-25 2003-04-25
US46539403P 2003-04-25 2003-04-25
US46547103P 2003-04-25 2003-04-25
US46557503P 2003-04-25 2003-04-25
US46561403P 2003-04-25 2003-04-25
US46556903P 2003-04-25 2003-04-25
US46560703P 2003-04-25 2003-04-25
US46553103P 2003-04-25 2003-04-25
US46556703P 2003-04-25 2003-04-25
US46546703P 2003-04-25 2003-04-25
US46554503P 2003-04-25 2003-04-25
US46559403P 2003-04-25 2003-04-25
US46558803P 2003-04-25 2003-04-25
US46571403P 2003-04-25 2003-04-25
US46534303P 2003-04-25 2003-04-25
US46533903P 2003-04-25 2003-04-25
US46555903P 2003-04-25 2003-04-25
US46558603P 2003-04-25 2003-04-25
US46564103P 2003-04-25 2003-04-25
US46560303P 2003-04-25 2003-04-25
US46563103P 2003-04-25 2003-04-25
US46528703P 2003-04-25 2003-04-25
US46558903P 2003-04-25 2003-04-25
US46537703P 2003-04-25 2003-04-25
US46566803P 2003-04-25 2003-04-25
US49331003P 2003-08-07 2003-08-07
US49330303P 2003-08-07 2003-08-07
US49542503P 2003-08-15 2003-08-15
US49573603P 2003-08-15 2003-08-15
US49564703P 2003-08-15 2003-08-15
US49533903P 2003-08-15 2003-08-15
US49536203P 2003-08-15 2003-08-15
US49568603P 2003-08-15 2003-08-15
US49541603P 2003-08-15 2003-08-15
US49542603P 2003-08-15 2003-08-15
US49564403P 2003-08-15 2003-08-15
US49538203P 2003-08-15 2003-08-15
US49578403P 2003-08-15 2003-08-15
US49568203P 2003-08-15 2003-08-15
US49539303P 2003-08-15 2003-08-15
US49553403P 2003-08-15 2003-08-15
US49529703P 2003-08-15 2003-08-15
US49538703P 2003-08-15 2003-08-15
US49578903P 2003-08-15 2003-08-15
US49564503P 2003-08-15 2003-08-15
US49548403P 2003-08-15 2003-08-15
US49575103P 2003-08-15 2003-08-15
US49556503P 2003-08-15 2003-08-15
US49576903P 2003-08-15 2003-08-15
US49568503P 2003-08-15 2003-08-15
US49552503P 2003-08-15 2003-08-15
US49552403P 2003-08-15 2003-08-15
US49566903P 2003-08-15 2003-08-15
US49562903P 2003-08-15 2003-08-15
US49552703P 2003-08-15 2003-08-15
US51408403P 2003-10-24 2003-10-24
US51415903P 2003-10-24 2003-10-24
US51394403P 2003-10-24 2003-10-24
US51396303P 2003-10-24 2003-10-24
US51446103P 2003-10-24 2003-10-24
US51439403P 2003-10-24 2003-10-24
US51397203P 2003-10-24 2003-10-24
US51445203P 2003-10-24 2003-10-24
US51414503P 2003-10-24 2003-10-24
US51411403P 2003-10-24 2003-10-24
US51420203P 2003-10-24 2003-10-24
US51411303P 2003-10-24 2003-10-24
US51392703P 2003-10-24 2003-10-24
US51416103P 2003-10-24 2003-10-24
US51448103P 2003-10-24 2003-10-24
US51396903P 2003-10-24 2003-10-24
US51356203P 2003-10-24 2003-10-24
US51398003P 2003-10-24 2003-10-24
US51411203P 2003-10-24 2003-10-24
US51395603P 2003-10-24 2003-10-24
US51429803P 2003-10-24 2003-10-24
US51397903P 2003-10-24 2003-10-24
US51358803P 2003-10-24 2003-10-24
US51393203P 2003-10-24 2003-10-24
US51392503P 2003-10-24 2003-10-24
US51425803P 2003-10-24 2003-10-24
US51439303P 2003-10-24 2003-10-24
US51414403P 2003-10-24 2003-10-24
US51410503P 2003-10-24 2003-10-24
US51408303P 2003-10-24 2003-10-24
US51411503P 2003-10-24 2003-10-24
US51434503P 2003-10-24 2003-10-24
US51434603P 2003-10-24 2003-10-24
US51436803P 2003-10-24 2003-10-24
US51410803P 2003-10-24 2003-10-24
US51413103P 2003-10-24 2003-10-24
US51392303P 2003-10-24 2003-10-24
US51397103P 2003-10-24 2003-10-24
US51432503P 2003-10-24 2003-10-24
US51394803P 2003-10-24 2003-10-24
US51435903P 2003-10-24 2003-10-24
US51424703P 2003-10-24 2003-10-24
US51356403P 2003-10-24 2003-10-24
US51442403P 2003-10-24 2003-10-24
US51430403P 2003-10-24 2003-10-24
US51420703P 2003-10-24 2003-10-24
US51394903P 2003-10-24 2003-10-24
US51423503P 2003-10-24 2003-10-24
US51443903P 2003-10-24 2003-10-24
US51436903P 2003-10-24 2003-10-24
US51397403P 2003-10-24 2003-10-24
US51446203P 2003-10-24 2003-10-24
US51396803P 2003-10-24 2003-10-24
US51392603P 2003-10-24 2003-10-24
US51428003P 2003-10-24 2003-10-24
US51433003P 2003-10-24 2003-10-24
US51947603P 2003-11-12 2003-11-12
US52434003P 2003-11-20 2003-11-20
US53223003P 2003-12-22 2003-12-22
US53194003P 2003-12-22 2003-12-22
US53216003P 2003-12-22 2003-12-22
US53196003P 2003-12-22 2003-12-22
US53259103P 2003-12-23 2003-12-23
US53600504P 2004-01-12 2004-01-12
US53600604P 2004-01-12 2004-01-12
US53600704P 2004-01-12 2004-01-12
US53605404P 2004-01-12 2004-01-12
PCT/US2004/013121 WO2004096235A2 (en) 2003-04-25 2004-04-26 Anti-cancer phosphonate analogs

Publications (1)

Publication Number Publication Date
MXPA05011287A true MXPA05011287A (es) 2006-01-24

Family

ID=40727234

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05011287A MXPA05011287A (es) 2003-04-25 2004-04-26 Analogos de fosfonato anti-cancer.

Country Status (2)

Country Link
MX (1) MXPA05011287A (es)
NO (1) NO20055592L (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1778251T3 (pl) * 2004-07-27 2011-09-30 Gilead Sciences Inc Koniugaty fosfonianowo-nukleozydowe jako środki przeciw wirusowi HIV

Also Published As

Publication number Publication date
NO20055592L (no) 2006-01-23
NO20055592D0 (no) 2005-11-25

Similar Documents

Publication Publication Date Title
WO2005002626A3 (en) Therapeutic phosphonate compounds
WO2004096286A3 (en) Antiviral phosphonate analogs
MXPA05011296A (es) Conjugados de fosfonato inhibidores de la cinasa.
TW200618804A (en) Phosphonate analogs of HIV inhibitor compounds
WO2004096285A3 (en) Anti-infective phosphonate conjugates
TW200614996A (en) Antiviral compounds
BRPI0409680A (pt) análogos de fosfonato anti-cáncer
TW200738741A (en) Antiviral compounds
TW200738742A (en) Antiviral compounds
WO2008005565A3 (en) Antiviral phosphinate compounds
MX2009013830A (es) Compuestos antivirales.
UA98494C2 (uk) Противірусні сполуки
WO2004096233A3 (en) Nucleoside phosphonate conjugates
TW200519096A (en) Quinazoline analogs as receptor tyrosine kinase inhibitors
MXPA05011294A (es) Compuestos de fosfonato anti-inflamatorios.
WO2004096287A3 (en) Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
WO2004096237A3 (en) Phosphonate analogs for treating metabolic diseases
MXPA05011289A (es) Compuestos de fosfato que tienen actividad inmunomoduladora.
UA90659C2 (ru) Аналоги хиназолина как ингибиторы рецепторных тирозинкиназ
MXPA05011287A (es) Analogos de fosfonato anti-cancer.
UA92464C2 (en) Antiviral compounds
UA96295C2 (en) Antiviral phosphinate compounds
WO2006047507A3 (en) Phosphonate substituted kinase inhibitors
BRPI0409677A (pt) análogos de fosfonato inibidores de cinase
UA98333C2 (en) Antiviral compounds

Legal Events

Date Code Title Description
FA Abandonment or withdrawal